SELENON and Respiratory insufficiency: In agreement with previous studies (Scoto et al., 2011), we characterized the clinical phenotype of RSMD1 patients with delayed motor milestones, slowly progressive muscle weakness, spinal rigidity, and progressive and potentially life-threatening respiratory insufficiency.